CYNERGISTEK INC/DE (CTEK) Fundamental Analysis & Valuation

NYSEARCA:CTEK • US23258P1057

Current stock price

1.25 USD
+0.02 (+1.63%)
At close:
1.25 USD
0 (0%)
After Hours:

This CTEK fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CTEK Profitability Analysis

1.1 Basic Checks

  • CTEK had negative earnings in the past year.
CTEK Yearly Net Income VS EBIT VS OCF VS FCFCTEK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 0 10M -10M

1.2 Ratios

Industry RankSector Rank
ROA -55.8%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CTEK Yearly ROA, ROE, ROICCTEK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 0 20 -20 -40 -60

1.3 Margins

Industry RankSector Rank
OM -43.25%
PM (TTM) -61.88%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
CTEK Yearly Profit, Operating, Gross MarginsCTEK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 0 50 -50

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

5

2. CTEK Health Analysis

2.1 Basic Checks

  • CTEK does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CTEK has more shares outstanding than it did 1 year ago.
  • CTEK has a better debt/assets ratio than last year.
CTEK Yearly Shares OutstandingCTEK Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2M 4M 6M 8M 10M
CTEK Yearly Total Debt VS Total AssetsCTEK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 10M 20M 30M 40M 50M

2.2 Solvency

  • CTEK has an Altman-Z score of 0.99. This is a bad value and indicates that CTEK is not financially healthy and even has some risk of bankruptcy.
  • There is no outstanding debt for CTEK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.99
ROIC/WACCN/A
WACC8.29%
CTEK Yearly LT Debt VS Equity VS FCFCTEK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 0 10M 20M 30M

2.3 Liquidity

  • A Current Ratio of 1.69 indicates that CTEK should not have too much problems paying its short term obligations.
  • A Quick Ratio of 1.69 indicates that CTEK should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.69
Quick Ratio 1.69
CTEK Yearly Current Assets VS Current LiabilitesCTEK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 5M 10M 15M 20M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. CTEK Growth Analysis

3.1 Past

  • The earnings per share for CTEK have decreased strongly by -52.63% in the last year.
  • The Revenue has decreased by -2.26% in the past year.
  • The Revenue for CTEK have been decreasing by -22.99% on average. This is quite bad
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16037.89%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y-8.55%
Revenue growth 5Y-22.99%
Sales Q2Q%1.76%

3.2 Future

  • CTEK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.71% yearly.
  • The Revenue is expected to grow by 17.89% on average over the next years. This is quite good.
EPS Next Y-23.1%
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
EPS Next 5Y34.71%
Revenue Next Year16.51%
Revenue Next 2Y18.47%
Revenue Next 3Y17.7%
Revenue Next 5Y17.89%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CTEK Yearly Revenue VS EstimatesCTEK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M
CTEK Yearly EPS VS EstimatesCTEK Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 0.2 -0.2 0.4 -0.4 0.6 -0.6

More info and screens

Find the best growth stocksShow best growing peers

1

4. CTEK Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for CTEK. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CTEK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CTEK Price Earnings VS Forward Price EarningsCTEK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -2.57
CTEK Per share dataCTEK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as CTEK's earnings are expected to grow with 36.03% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.72%
EPS Next 3Y36.03%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CTEK Dividend Analysis

5.1 Amount

  • CTEK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CTEK Fundamentals: All Metrics, Ratios and Statistics

CYNERGISTEK INC/DE

NYSEARCA:CTEK (8/31/2022, 8:04:02 PM)

After market: 1.25 0 (0%)

1.25

+0.02 (+1.63%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength45.96
Industry Growth88.2
Earnings (Last)08-15
Earnings (Next)11-09
Inst Owners5.97%
Inst Owner Change0%
Ins Owners2.94%
Ins Owner Change0%
Market Cap16.57M
Revenue(TTM)16.86M
Net Income(TTM)-10.43M
Analysts43.33
Price Target1.27 (1.6%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.98
P/FCF N/A
P/OCF N/A
P/B 1.09
P/tB N/A
EV/EBITDA -2.57
EPS(TTM)-0.29
EYN/A
EPS(NY)-0.31
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS1.27
BVpS1.15
TBVpSN/A
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -55.8%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -43.25%
PM (TTM) -61.88%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y0%
ROICexgc growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score3
Asset Turnover0.9
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.69
Quick Ratio 1.69
Altman-Z 0.99
F-Score3
WACC8.29%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-16037.89%
EPS Next Y-23.1%
EPS Next 2Y-2.72%
EPS Next 3Y36.03%
EPS Next 5Y34.71%
Revenue 1Y (TTM)-2.26%
Revenue growth 3Y-8.55%
Revenue growth 5Y-22.99%
Sales Q2Q%1.76%
Revenue Next Year16.51%
Revenue Next 2Y18.47%
Revenue Next 3Y17.7%
Revenue Next 5Y17.89%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

CYNERGISTEK INC/DE / CTEK Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CYNERGISTEK INC/DE (CTEK) stock?

ChartMill assigns a fundamental rating of 3 / 10 to CTEK.


What is the valuation status of CYNERGISTEK INC/DE (CTEK) stock?

ChartMill assigns a valuation rating of 2 / 10 to CYNERGISTEK INC/DE (CTEK). This can be considered as Overvalued.


How profitable is CYNERGISTEK INC/DE (CTEK) stock?

CYNERGISTEK INC/DE (CTEK) has a profitability rating of 1 / 10.